Laryngitis after inhalation of liposomal amikacin

Clin Case Rep. 2022 Feb 20;10(2):e05350. doi: 10.1002/ccr3.5350. eCollection 2022 Feb.

Abstract

A 56-year-old woman with pulmonary Mycobacterium avium complex disease was started on inhalation liposomal amikacin. One month later, she developed hoarseness and was diagnosed with laryngitis. The laryngitis healed immediately after treatment discontinuation, and no recurrence occurred even after resuming intermittent inhalation.

Keywords: Mycobacterium avium complex (MAC); amikacin liposomal inhalation suspension (ALIS); hoarseness; laryngitis.